|
|
NeuroSearch A/S - Price Analysis Snapshot
This Report features up to a ten-year record of the equity Price history for NeuroSearch A/S. Tabular results include the High, Low and Closing price for the quarter. There is also a calculation of percentage change in price for both Quarterly and Annual periods. Price values are adjusted for stock splits and dividends.
NeuroSearch A/S. The Group's principal activity is to invent, develop and market drugs. The Group focuses on research and development of drugs, primarily targeting diseases related to the central nervous system. The products of the Group are sold mainly to the pharmaceutical industry and later on to patients suffering from diseases that are highly disabling such as ADHD, anxiety disorders, cancer, COPD, depression, epilepsy, pain and Parkinson's disease. The Group's research has also led to research and development projects related to other diseases such as obesity, cancer, urinary incontinence and certain heart diseases. The Group operates in the Nordic region.
Not the Report you are looking for? Click here for more browsing options.
Layout and Content of a Typical Report
|
|
|
|
|